Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
M
Maze Therapeutics Inc
NASDAQ:MAZE
Maze Therapeutics Inc
NASDAQ:MAZE
Price:
33.38
USD
3.5%
Market Cap:
$1.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Maze Therapeutics Inc
NASDAQ:MAZE
|
US |
|
C
|
Chevron Corp
XHAM:CHV
|
US |
|
Exlservice Holdings Inc
NASDAQ:EXLS
|
US |
|
C
|
China Coal Energy Co Ltd
F:CVV
|
CN |
|
HKT Trust and HKT Ltd
OTC:HKTTF
|
HK |
Wall St Price Targets
MAZE Price Forecast
Based on 15 analysts
Based on 15 analysts
+70% Upside
from
$33.38
today
Maze Therapeutics Inc (MAZE)’s 12-month stock price forecast through November 2027 has a consensus target of $56.61, implying 70% upside. The forecast is based on price targets from 15 Wall Street analysts.
Maze Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MAZE's stock price target?
Price Target
56.61
USD
56.61
USD
According to Wall Street analysts, the average 1-year price target for MAZE is 56.61 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.